Trending
- Zoldonrasib Yields Encouraging Activity in KRAS G12D+ NSCLC
- New Frontiers in Adjuvant Care: Evaluating Elacestrant in the ELEGANT Trial
- Nivolumab/AVD: A New Standard in Untreated Advanced Hodgkin Lymphoma
- DeepFAN, a transformer-based model for human–artificial intelligence collaborative assessment of incidental pulmonary nodules in CT scans: a multireader, multicase trial
- STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more
- What Median OS Did Daraxonrasib Achieve in Pretreated PDAC?
- US Health Secretary Kennedy Distances Himself From FDA’s Replimune Cancer Drug Rejection
- Autogene Cevumeran & The Future of Personalized Cancer Vaccines
